Articles written by: Tomi Crowe

Fortinet Inc. (FTNT) and Its Peers Financial Results Comparison

As Application Software company, Fortinet Inc. (NASDAQ:FTNT) is competing with its peers based on the analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation. Institutional & Insider Ownership 76.4% of Fortinet Inc.’s shares are held by institutional investors. Comparatively, 59.81% of all Application Software’s companies shares are held by […]

Dorsey Wright & Associates Lowered Aes Com (AES) Position By $1.92 Million; Destination Maternity (DEST) Sentiment Is 0.54

Dorsey Wright & Associates Lowered Aes Com (AES) Position By $1.92 Million; Destination Maternity (DEST) Sentiment Is 0.54

Destination Maternity Corp (DEST) investors sentiment decreased to 0.54 in 2019 Q2. It’s down -0.29, from 0.83 in 2019Q1. The ratio is negative, as 7 funds increased or opened new holdings, while 13 sold and reduced their stock positions in Destination Maternity Corp. The funds in our database now have: […]

Reviewing Celyad SA (CYAD)’s and Vascular Biogenics Ltd. (NASDAQ:VBLT)’s results

As Biotechnology businesses, Celyad SA (NASDAQ:CYAD) and Vascular Biogenics Ltd. (NASDAQ:VBLT), are affected by contrast. This especially applies to their risk, analyst recommendations, profitability, institutional ownership, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Celyad SA 9 0.00 9.45M -7.01 […]

Reviewing Wyndham Hotels & Resorts Inc. (WH)’s and Hilton Worldwide Holdings Inc. (NYSE:HLT)’s results

Both Wyndham Hotels & Resorts Inc. (NYSE:WH) and Hilton Worldwide Holdings Inc. (NYSE:HLT) are Lodging companies, competing one another. We will compare their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Wyndham Hotels & […]

Comparison of Bio-Techne Corporation (TECH) and uniQure N.V. (NASDAQ:QURE)

We are contrasting Bio-Techne Corporation (NASDAQ:TECH) and uniQure N.V. (NASDAQ:QURE) on their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. They both are Biotechnology companies, competing one another. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bio-Techne Corporation 204 3.92 37.91M 3.10 […]

Evofem Biosciences Inc. (EVFM)’s Financial Results Comparing With Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)

Evofem Biosciences Inc. (NASDAQ:EVFM) and Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), both competing one another are Biotechnology companies. We will contrast their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Evofem Biosciences Inc. 5 -0.10 32.21M […]

ZIOPHARM Oncology Inc. (ZIOP)’s Financial Results Comparing With Constellation Pharmaceuticals Inc. (NASDAQ:CNST)

ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) and Constellation Pharmaceuticals Inc. (NASDAQ:CNST) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects such as dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income […]

Spero Therapeutics Inc. (SPRO)’s Financial Results Comparing With Vascular Biogenics Ltd. (NASDAQ:VBLT)

Spero Therapeutics Inc. (NASDAQ:SPRO) and Vascular Biogenics Ltd. (NASDAQ:VBLT) are two firms in the Biotechnology that compete against each other. Below is a comparison of their institutional ownership, profitability, risk, dividends, analyst recommendations, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio […]